title: Simvastatin co-prescribed with protease inhibitors despite dangerous drug interactions.
authors.forename: Katherine M
authors.initials: KM
authors.lastname: Coyne
authors.forename: Marta
authors.initials: M
authors.lastname: Boffito
authors.forename: Nick
authors.initials: N
authors.lastname: Theobald
authors.forename: David
authors.initials: D
authors.lastname: Asboe
mesh_terms: D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008131:London; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D019821:Simvastatin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000960:Hypolipidemic Agents; D011480:Protease Inhibitors; D019821:Simvastatin